Drug Type TCR therapy |
Synonyms LT-V20, LTCR-O1-1 |
Target |
Mechanism CMV protein inhibitors(CMV Protein inhibitors), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Lion TCR Pte Ltd.Startup |
Active Organization- |
Inactive Organization Lion TCR Pte Ltd.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft Rejection | Preclinical | SG | Lion TCR Pte Ltd.Startup | - |